arXiv:2606. 08305v1 Announce Type: cross Abstract: Externally controlled survival trials are increasingly used when concurrent randomized controls are infeasible, particularly in oncology and rare-disease settings with time-to-event endpoints.
By Se Yoon Lee, Yonghyun Kwon, Jae Kwang Kim
arXiv:2608. 00271v1 Announce Type: cross Abstract: A wide range of statistical and machine learning methods have been proposed for survival analysis with competing risks, where the occurrence of one event (i.
By Bego\~na B. Sierra, Colin McLean, Peter S. Hall, Sarah Friedrich-Welz, Catalina A. Vallejos
arXiv:2607.09431v2 Announce Type: replace-cross
Abstract: Medical time-to-event data are frequently subject to competing risks, where the occurrence of one terminal event precludes the others and sta...
By Sunny Yang, Weiyan Zhao, Wanqi Zhao
arXiv:2606. 03689v1 Announce Type: cross Abstract: Survival Analysis (SA) is a statistical framework that models the time span until some event of interest occurs.
By Mariana Vargas Vieyra
arXiv:2601. 22259v2 Announce Type: replace Abstract: While tabular foundation models have achieved remarkable success in classification and regression, adapting them to model time-to-event outcomes for survival analysis is non-trivial due to right-censoring, where data observations may end before the event of interest occurs.
By Da In Kim, Wei Siang Lai, Kelly W. Zhang
arXiv:2609.38181v1 Announce Type: new
Abstract: Survival analysis estimates time-to-event outcomes from patient covariates and is widely used for medical risk assessment. Patients seeking prognostic...
By Juan M Zambrano Chaves, Peniel Argaw, Risa Ueno, Carlo Bifulco, Kristina Young, Rom Leidner, Tristan Naumann, Hoifung Poon
arXiv:2606. 12006v1 Announce Type: cross Abstract: Predicting time-to-event outcomes such as mortality is a fundamental task in clinical decision-making, commonly addressed through survival analysis.
By Minh-Khoi Pham, Luca Cotugno, Alina Sirbu, Tai Tan Mai, Martin Crane, Marija Bezbradica
arXiv:2606. 23871v1 Announce Type: new Abstract: Survival analysis is central to clinical decision-making, yet reliable time-to-event models require large, diverse cohorts that are rarely available at a single institution, while privacy regulations restrict the centralization of patient data.
By Natalia Moreno-Blasco, Anusha Ihalapathirana, Pekka Siirtola, Miguel Fernandez-de-Retana
arXiv:2608. 06288v1 Announce Type: new Abstract: This work presents a novel attention-based framework for estimating the Individual Probability of Treatment Benefit (IPTB) in survival analysis contexts.
By Lev V. Utkin, Stanislav K. Kogan, Andrei V. Konstantinov
The paper explores how to adapt tabular foundation models (TabFMs) for censored time‑to‑event prediction by linking them with CoxPH and DeepHit and revising training procedures. It evaluates zero‑shot, classification‑based fine‑tuning, and survival‑head adaptations across 74 single‑risk and 4 competing‑risk datasets, finding that zero‑shot works best on small datasets while supervised adaptation excels as data grows. The study shows that the choice of adaptation interface and data regime critically influences TabFM transfer performance.
By Minh-Khoi Pham, Luca Cotugno, Dan Cernei, Alina Sirbu, Stefano Masi, Giuseppe Prencipe, Alessandro Pingitore, Patrizia Landi, Working Group on Uric Acid, Cardiovascular Risk of the Italian Society of Hypertension, Tai Tan Mai, Martin Crane, Marija Bezbradica
arXiv:2608. 04025v1 Announce Type: cross Abstract: Whole-slide survival models commonly provide risk rankings without calibrated statements about individual event times.
By Mingi Hong
arXiv:2212. 05260v4 Announce Type: replace-cross Abstract: Proper scoring rules encourage probabilistic predictions that match the true underlying distribution and are central to model evaluation, with increasing relevance in automated workflows such as AutoML.
By John Zobolas, Raphael Sonabend, Riccardo De Bin, Johannes Piller, Philipp Kopper, Lukas Burk, Andreas Bender